The stakes stopped being abstract: URMC paid $2.85 million and Froedtert $2 million in matters rooted in marketing-side data disclosures, Cerebral's ad-data sharing became the FTC's telehealth example, and Klaviyo deplatformed telehealth senders rather than carry health data in a marketing tool. Reputation platforms sit in the same seat: patient identities, message content, and treatment context, held by a marketing vendor.

Here's the 2026 comparison, without the vendor gloss.

The short verdicts

Podium: conditionally. Podium will sign a BAA for eligible healthcare customers and has HIPAA-oriented features on the right plan. It is not compliant by default — a standard account texting patients has no BAA coverage, and several of the platform's most-used behaviors (webchat capturing visitor messages, AI-drafted replies, payment requests over text) need explicit configuration to stay inside the lines.

Birdeye: conditionally, with the same asterisks. Birdeye also offers a BAA for healthcare accounts and markets HIPAA readiness. Same reality: the BAA is plan- and paperwork-dependent, defaults are built for home services and auto dealers, and compliance lives in how you configure inboxes, users, and integrations.

For both: the BAA exists if you ask, the danger is everything the BAA doesn't configure for you.

Where practices actually get burned

1. Review replies that confirm patienthood

The #1 HIPAA violation in this category isn't the software — it's the reply box. Responding to a review with "Thanks for coming in Tuesday, glad the crown feels great!" confirms the reviewer is your patient and discloses treatment. Even replying to a negative review with clinical detail ("our records show you missed two appointments") is a disclosure — OCR has fined practices for exactly this. The compliant reply pattern: generic, no confirmation of care ("We take all feedback seriously; please call our office"), regardless of what the reviewer themselves disclosed.

Neither Podium nor Birdeye can make your office manager write compliant replies. Templates and training can. (Full rules: Can My Practice Post Patient Reviews? HIPAA Rules for Testimonials.)

2. Review requests are texts — TCPA and A2P 10DLC apply

A review request SMS is a business text message: it needs consent, opt-out handling, quiet hours, and a sender registered under A2P 10DLC — the carrier registration regime that filters or blocks unregistered business texting. Both platforms handle registration for their managed numbers, but your consent trail is your problem: patients must have agreed to receive texts, opt-outs must be honored everywhere (not just inside the review tool), and a review-request blast to an old patient CSV is a class-action-shaped event at $500–$1,500 per message. The full texting rulebook: HIPAA-Compliant SMS Marketing: TCPA, A2P 10DLC, and Consent Done Right.

3. Gating and incentives violate platform rules (and sometimes the FTC)

"Send happy patients to Google, unhappy ones to a private form" — review gating — violates Google's policies and draws FTC attention under the 2024 fake-reviews rule. Both platforms have historically made gating easy; both now warn against it. Ask everyone a review, publicly, or don't ask.

4. The unified inbox becomes an unencrypted patient record

The pitch — webchat + texts + Facebook messages in one inbox — means patient conversations (symptoms, appointment details, insurance questions) accumulate in the vendor's system indefinitely, accessible to every seat on the account. Questions to answer before trusting it: Is message content encrypted beyond transport? Who can read which threads? Is access logged in a way you could produce for OCR? Retention controls? On generalist platforms, honest answers range from "partially" to "no."

5. Integrations leak sideways

EHR/PMS syncs (to auto-trigger review requests after visits) move appointment data into the platform; Zapier hooks and CSV exports move it back out to tools with no BAA. Every connection needs its own audit — the BAA doesn't travel.

Podium vs Birdeye vs doing it natively

The reputation-tool checklist (ungated)

1. BAA signed and countersigned — for the plan you're actually on.
2. Review-request texting: consent captured and stored; opt-outs synced across all systems; A2P registration confirmed.
3. No gating: every patient asked, same public destination.
4. Review-reply policy in writing: never confirm patienthood, never reference care — with templates at the front desk.
5. Inbox access role-scoped; MFA on; ex-staff seats revoked same-day.
6. Message retention and deletion policy set (default is forever).
7. Every integration audited for what patient data it moves and where.
8. Incentivized reviews: none, anywhere (FTC + platform rules).
9. Export discipline: no patient CSVs leaving the BAA boundary.
10. Documented risk assessment covering the tool — dated, on file.

The do-marketing answer

Reviews and two-way messaging are worth doing — review velocity is a top-3 local ranking factor, and practices that text back in under 5 minutes win the patient. The question is whether you assemble it from a generalist tool plus a BAA plus a training program, or run it on healthcare-native infrastructure where the consent capture, per-message compliance checks, opt-out enforcement, encryption, and audit logging are already wired — with our team requesting the reviews, writing the compliant replies, and working the inbox for you. That's the PilotPractice version.

See what your current stack exposes: run the free PHI leak scanner on your website — flags chat widgets and scripts sending visitor data to third parties. Ungated.

Then book a demo — we'll show review automation, compliant reply workflows, and the message audit log on a live practice account.

Related: HIPAA-Compliant SMS Marketing · Can My Practice Post Patient Reviews? · The 2026 Guide to HIPAA-Compliant Marketing

Security details: trust.pilotpractice.com